Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220658051> ?p ?o ?g. }
- W4220658051 endingPage "121474" @default.
- W4220658051 startingPage "121474" @default.
- W4220658051 abstract "Traditional medication is not satisfied in rheumatoid arthritis (RA) therapy due to its long-term side effects and failure in cartilage repair. Nanomodification of mesenchymal stem cells (MSCs) holds promise for lifting such hurdles but delivering therapeutic nanomaterials (NPs) into MSCs remains challenging in this new strategy. Here, we show that CuS@MnO2 NPs functionalized with a short phage-selected MSC-targeting peptide enabled the NPs to be uptaken by MSCs. The resultant NP-modified MSCs, further loaded with metformin, significantly improved stem cell therapy of RA. Specifically, the NP-modified MSCs survived the RA-associated oxidized stress through regulating the stress by the superoxide dismutase (SOD)- and catalase (CAT)-like activity of the NPs. They also exhibited an increased capability of cell migration, anti-inflammation, and chondrogenesis due to the nanomodification, thereby effectively inhibiting synovial inflammation and reducing cartilage erosion to relieve RA symptoms in two rat models 28 days post intravenous injection. Our peptide-promoted NP-modified MSCs may be used to enhance therapeutic effects in treating not only RA but also other degenerative and inflammatory diseases." @default.
- W4220658051 created "2022-04-03" @default.
- W4220658051 creator A5000859290 @default.
- W4220658051 creator A5008423769 @default.
- W4220658051 creator A5019886822 @default.
- W4220658051 creator A5029946717 @default.
- W4220658051 creator A5029998675 @default.
- W4220658051 creator A5035701638 @default.
- W4220658051 creator A5044748905 @default.
- W4220658051 creator A5059839949 @default.
- W4220658051 creator A5060672746 @default.
- W4220658051 creator A5076042378 @default.
- W4220658051 date "2022-04-01" @default.
- W4220658051 modified "2023-10-17" @default.
- W4220658051 title "Highly effective rheumatoid arthritis therapy by peptide-promoted nanomodification of mesenchymal stem cells" @default.
- W4220658051 cites W1600024584 @default.
- W4220658051 cites W1650284538 @default.
- W4220658051 cites W1854383303 @default.
- W4220658051 cites W2006601515 @default.
- W4220658051 cites W2013313311 @default.
- W4220658051 cites W2022481046 @default.
- W4220658051 cites W2038535814 @default.
- W4220658051 cites W2051877723 @default.
- W4220658051 cites W2061412466 @default.
- W4220658051 cites W2086385875 @default.
- W4220658051 cites W2100125044 @default.
- W4220658051 cites W2128926357 @default.
- W4220658051 cites W2131882149 @default.
- W4220658051 cites W2137153310 @default.
- W4220658051 cites W2149033728 @default.
- W4220658051 cites W2151477385 @default.
- W4220658051 cites W2235731915 @default.
- W4220658051 cites W2296523452 @default.
- W4220658051 cites W2310415701 @default.
- W4220658051 cites W2319957449 @default.
- W4220658051 cites W2321952777 @default.
- W4220658051 cites W2408830150 @default.
- W4220658051 cites W2539871382 @default.
- W4220658051 cites W2558487321 @default.
- W4220658051 cites W2560577160 @default.
- W4220658051 cites W2613818341 @default.
- W4220658051 cites W2622000437 @default.
- W4220658051 cites W2622692072 @default.
- W4220658051 cites W2756282825 @default.
- W4220658051 cites W2765979567 @default.
- W4220658051 cites W2786474781 @default.
- W4220658051 cites W2791115506 @default.
- W4220658051 cites W2794504806 @default.
- W4220658051 cites W2807564415 @default.
- W4220658051 cites W2808205734 @default.
- W4220658051 cites W2883487035 @default.
- W4220658051 cites W2884259267 @default.
- W4220658051 cites W2884992637 @default.
- W4220658051 cites W2889191136 @default.
- W4220658051 cites W2905491630 @default.
- W4220658051 cites W2920324197 @default.
- W4220658051 cites W2921649378 @default.
- W4220658051 cites W2947046988 @default.
- W4220658051 cites W2967299079 @default.
- W4220658051 cites W2972832815 @default.
- W4220658051 cites W2982115737 @default.
- W4220658051 cites W3019173743 @default.
- W4220658051 cites W3025799594 @default.
- W4220658051 cites W3028618163 @default.
- W4220658051 cites W3035942129 @default.
- W4220658051 cites W3041032315 @default.
- W4220658051 cites W3046028219 @default.
- W4220658051 cites W3212239329 @default.
- W4220658051 cites W4211111012 @default.
- W4220658051 cites W4213013932 @default.
- W4220658051 doi "https://doi.org/10.1016/j.biomaterials.2022.121474" @default.
- W4220658051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35316662" @default.
- W4220658051 hasPublicationYear "2022" @default.
- W4220658051 type Work @default.
- W4220658051 citedByCount "6" @default.
- W4220658051 countsByYear W42206580512022 @default.
- W4220658051 countsByYear W42206580512023 @default.
- W4220658051 crossrefType "journal-article" @default.
- W4220658051 hasAuthorship W4220658051A5000859290 @default.
- W4220658051 hasAuthorship W4220658051A5008423769 @default.
- W4220658051 hasAuthorship W4220658051A5019886822 @default.
- W4220658051 hasAuthorship W4220658051A5029946717 @default.
- W4220658051 hasAuthorship W4220658051A5029998675 @default.
- W4220658051 hasAuthorship W4220658051A5035701638 @default.
- W4220658051 hasAuthorship W4220658051A5044748905 @default.
- W4220658051 hasAuthorship W4220658051A5059839949 @default.
- W4220658051 hasAuthorship W4220658051A5060672746 @default.
- W4220658051 hasAuthorship W4220658051A5076042378 @default.
- W4220658051 hasConcept C105702510 @default.
- W4220658051 hasConcept C10882517 @default.
- W4220658051 hasConcept C126322002 @default.
- W4220658051 hasConcept C142724271 @default.
- W4220658051 hasConcept C192562407 @default.
- W4220658051 hasConcept C198826908 @default.
- W4220658051 hasConcept C203014093 @default.
- W4220658051 hasConcept C2775838275 @default.
- W4220658051 hasConcept C2776151105 @default.
- W4220658051 hasConcept C2776914184 @default.